Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.9751
+0.0326 (3.46%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Immunic Employees
Immunic had 91 employees as of December 31, 2024. The number of employees increased by 14 or 18.18% compared to the previous year.
Employees
91
Change (1Y)
14
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$1,104,473
Market Cap
93.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
IMUX News
- 8 days ago - Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - PRNewsWire
- 10 days ago - Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments - PRNewsWire
- 18 days ago - Immunic, Inc. to Participate in Scientific and Industry Conferences in April - PRNewsWire
- 6 weeks ago - Immunic to Participate in Scientific and Investor Conferences in March - PRNewsWire
- 7 weeks ago - Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis - PRNewsWire
- 2 months ago - Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing - PRNewsWire
- 2 months ago - Immunic to Participate in Investor and Scientific Conferences in February - PRNewsWire
- 3 months ago - Immunic Highlights 2024 Accomplishments and Upcoming Milestones - PRNewsWire